Induction of eruptive benign melanocytic naevi by immune suppressive agents, including biologicals

The British Journal of Dermatology
H J BovenschenP C M van de Kerkhof

Abstract

Eruptive naevi have been described to potentially arise in immune compromised patients. We describe three patients with eruptive benign melanocytic naevi during a phase of immunosuppressive therapy. METHODS/DIAGNOSIS: Two patients with Crohn disease were treated with either azathioprine monotherapy or a combination of azathioprine and infliximab, when eruptive naevi arose particularly at the palms and soles. Our third patient with plaque psoriasis developed eruptive naevi during two episodes of treatment: during a course with the biological agent alefacept and during etanercept therapy. We conclude that treatment with the recently available biological agents might be associated with the formation of eruptive naevi. Although positive evidence for the occurrence of malignant pigmented lesions is lacking, alertness to the development of eruptive melanocytic naevi during treatment with biological agents is indicated.

References

Aug 1, 1977·Archives of Dermatology·A W KopfJ C Mitchell
Dec 1, 1979·Journal of the American Academy of Dermatology·K SoltaniA L Lorincz
Sep 1, 1978·Archives of Dermatology·G Goerz, D Tsambaos
Nov 1, 1978·The British Journal of Dermatology·J D Kirby, C R Darley
Mar 1, 1991·Clinical and Experimental Dermatology·J M McGregorD M MacDonald
Apr 1, 1991·International Journal of Dermatology·I BetllochA Vilar
Jan 1, 1990·Medical and Pediatric Oncology·P E de WitF H Rampen
Sep 1, 1990·Archives of Dermatology·H H Ibsen, O Clemmensen
Jul 8, 1989·BMJ : British Medical Journal·B R HughesC C Bailey
May 1, 1989·The Journal of Investigative Dermatology·D E Elder
Mar 1, 1988·Clinical and Experimental Dermatology·J N Barker, D M MacDonald
Nov 1, 1986·Journal of the American Academy of Dermatology·S A SmithD E Vander Ploeg
Aug 1, 1984·Journal of Cutaneous Pathology·K SoltaniB R Apatoff
Apr 1, 1984·European Journal of Pediatrics·K HeyneH G Hansen
Apr 1, 1995·The Journal of Dermatology·H W BongK Y Chung
Nov 1, 1996·The Journal of Investigative Dermatology·J J GrobJ C Guillaume
Apr 3, 1999·Journal of the American Academy of Dermatology·A FiroozY Dowlati
Mar 22, 2001·Journal of the American Academy of Dermatology·J W BauerH Hintner
Sep 11, 2002·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·C UlrichE Stockfleth
Aug 7, 2003·Inflammatory Bowel Diseases·Konstantinos H KatsanosEpameinondas V Tsianos
Nov 12, 2003·Acta Dermato-venereologica·Christoph M LanschuetzerJohann W Bauer
Nov 26, 2003·Journal of the American Academy of Dermatology·Mauro AlaibacAnna Belloni-Fortina
May 19, 2004·Archives of Dermatology·Josep Malvehy, Susana Puig
Apr 7, 2005·International Journal of Dermatology·Marilena KakridaRamsey Markus
Apr 29, 2005·Journal of the American Academy of Dermatology·Justin Woodhouse, Edward V Maytin

❮ Previous
Next ❯

Citations

Jun 19, 2008·Archives of Dermatology·Heidi H KongChristine Chevreau
Sep 26, 2012·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·S A BraunS Hanneken
Sep 25, 2012·The American Journal of Dermatopathology·Mai P Hoang, Daniela Kroshinsky
Jul 17, 2007·Current Opinion in Pediatrics·Julie V Schaffer
Jun 6, 2009·American Journal of Clinical Dermatology·Guillermo VillalónEsperanza Jordá
Mar 1, 2012·ISRN Dermatology·Andrew L RossJames M Grichnik
Mar 10, 2012·Journal of Crohn's & Colitis·Janneke WondersStijn J B Van Weyenberg
Sep 14, 2007·The Journal of Dermatological Treatment·H Jorn BovenschenMarieke M B Seyger
Jul 19, 2011·Expert Opinion on Biological Therapy·Claudine Piérard-FranchimontPascale Quatresooz
Jul 7, 2012·Reumatología clinica·Maria Victoria HernándezRaimon Sanmartí
Oct 2, 2012·Dermatologic Clinics·Joshua W HagenA Neil Crowson
Oct 8, 2011·Annales de dermatologie et de vénéréologie·J-L Michel
Jul 25, 2009·Journal of the American Academy of Dermatology·Aikaterini-Evaggelia MoustouAlexander J Stratigos
Oct 22, 2008·Annales de dermatologie et de vénéréologie·M Bennani-LahlouC Robert
Jan 24, 2008·International Journal of Dermatology·Ronni WolfBatya Davidovici
Aug 18, 2012·The Australasian Journal of Dermatology·Stephanie Jane Arnold, Jonathan Bowling
Aug 19, 2010·The British Journal of Dermatology·A SekulicM R Pittelkow
Aug 30, 2012·International Journal of Dermatology·Collette McCourtSusannah Hoey
Jun 11, 2009·Clinical and Experimental Dermatology·M E VestergaardD F Murrell
Jan 6, 2010·Journal of the European Academy of Dermatology and Venereology : JEADV·D NashanS Hofmann
Oct 31, 2009·Clinical and Experimental Dermatology·D DeU N Saikia
May 23, 2013·Clinical and Experimental Dermatology·I KoelemijR van Doorn
Feb 13, 2013·Journal of the European Academy of Dermatology and Venereology : JEADV·I ZalaudekI Neri
Jul 19, 2012·Acta Parasitologica·Aleksandra GarbacewiczBarbara Grytner-Zięcina
Oct 21, 2016·Expert Opinion on Drug Metabolism & Toxicology·Gino A VenaGiuseppe Argenziano
Jan 31, 2017·The American Journal of Dermatopathology·Jonathan J LeeMai P Hoang
Mar 5, 2014·Experimental Dermatology·James M GrichnikKonstantinos E Hatzistergos
Sep 30, 2017·International Journal of Dermatology·Alba Calleja-AlgarraVerónica Monsálvez Honrubia
Oct 11, 2017·Clinical and Experimental Dermatology·G Kravvas, G M Kavanagh
Oct 24, 2017·The American Journal of Dermatopathology·Martina LambertiniEmi Dika
Feb 16, 2018·Dermatology Practical & Conceptual·Ali TareenTine Vestergaard
Aug 8, 2019·Clinical and Experimental Dermatology·C O'KeeffeC Feighery
Apr 30, 2020·Dermatologic Therapy·Fatma Pelin CengizNahide Onsun
Feb 6, 2009·Melanoma Research·Edoardo ZattraMauro Alaibac
Jan 31, 2016·The American Journal of Dermatopathology·Claudia Ramos-RodríguezCarlos Mendoza-Chaparro
May 24, 2019·American Journal of Clinical Dermatology·Ewa A Burian, Gregor B E Jemec
Oct 22, 2013·Journal of Cutaneous Medicine and Surgery·Thomas G Salopek, Muhammad N Mahmood
Nov 6, 2020·Cancer Prevention Research·Tahseen H NastiCraig A Elmets
Nov 18, 2021·Pediatric Dermatology·Janna M VassantachartJoyce M C Teng

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of the American Academy of Dermatology
Justin Woodhouse, Edward V Maytin
Journal of the European Academy of Dermatology and Venereology : JEADV
I Rodriguez-BlancoJ Toribio
North Carolina Medical Journal
P S Pegram
© 2022 Meta ULC. All rights reserved